Operating Grant : 9th Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) (Diagnostics and Surveillance of Antimicrobial Resistance: Development of tools, technologies and methods for global use)
Eligibility to Apply
For an application to be eligible:
- The Nominated Principal Applicant must be an independent researcher
- The Nominated Principal Applicant must be appointed at an eligible institution (see Institutional Eligibility Requirements for eligibility process and associated timelines) at the time of application.
For additional CIHR eligibility requirements for individuals, refer to the Individual Eligibility Requirements.
For more information on JPIAMR, please consult the JPIAMR website.
Addressing the rising threat of antimicrobial resistance (AMR) requires a holistic and multi-sectoral approach – referred to as One Health. Resistant bacteria and antibiotics can be found in humans, animals and the environment, and they may spread from one to the other, and from one country to another. AMR does not recognize geographic or human–animal borders. The primary aim of the ninth joint call of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) is to combine the resources, infrastructures, and strengths of multiple countries in order to facilitate innovative research projects on diagnostics and surveillance strategies that can be used to detect and monitor antimicrobial resistance (AMR).
The call focuses on the development of new or improved diagnostics and surveillance strategies, tools, technologies and methods that can be used to aid the diagnosis of AMR infections in human and veterinary settings, or the surveillance and detection of AMR in humans, animals and the environment. Projects addressing both human and veterinary diagnostic and surveillance topics may also consider how research on prevention and prudent use of antibiotics could optimise the efficacy and safety of antimicrobial chemotherapy. Projects should consider implementation into appropriate geographic settings, including into low and middle income countries (LMICs), and assume a One Health perspective where appropriate.
Another aim of this call is to support and increase the participation of researchers from LMICs. Research and innovation on AMR by and within LMICs has great importance for our collective global future. AMR thrives in settings with limited access to water and sanitation, medicines, veterinary and health care, and geographic environments where antimicrobials are produced and applied and pose increased and unknown risks for humans, animals and the environment.
Projects should aim to either:
- Develop strategies, tools, technologies, and methods for the detection, monitoring, profiling and/or surveillance of antimicrobial resistance and dynamics leading to resistance.
- Study ways to facilitate and implement the uptake and use of existing strategies, tools, technologies, and/or methods for the detection, monitoring, profiling and surveillance of antimicrobial resistance and dynamics leading to resistance.
Projects should consider international guidelines and standards for surveillance AMR.